All Insights Articles

Yale SOM leadership expert Jeffrey Sonnenfeld asks if the CEO’s eccentricities and forgotten promises are undermining his leadership of Twitter, Tesla, and SpaceX.

The first drugs using the CRISPR technique are approaching the market, with the potential to transform the lives of people with certain genetic illnesses. We talked with Dr. Greg Licholai about the state of the technology.

Yale SOM leadership expert Jeffrey Sonnenfeld writes that cynical media coverage and unwarranted concern over Biden’s age have muted the remarkable achievements of his first term.

Before teaching a personal finance course, Prof. James Choi dipped into some popular books on the topic. He found that much of what personal finance gurus suggest is at odds with economic research—but that they also have insights into human nature that are sometimes missing from economic analyses.

Yale SOM’s Jeffrey Sonnenfeld and Steven Tian write that the historic settlement and the revelations that preceded it have left Fox Corporation damaged and vulnerable to additional litigation.

In the 1990s, Nelson modernized the shipping company and gave it a new focus on the customer. Yale SOM’s Jeffrey Sonnenfeld remembers the former CEO, who died on April 6.

For families coming out of homelessness, housing doesn’t end the impossible choices that come with navigating poverty. Jill Bauman ’87 describes Imagine LA’s holistic model to end family homelessness and poverty.

Yale SOM’s Jeffrey Sonnenfeld writes that Iger offered a master class in standing up to bullies when he undercut the Florida governor’s attempt to impose new oversight on Walt Disney World.